-Dow Jones, citing WSJ
Conduit Pharmaceuticals Partners With ClinConnect On Cocrystal Development Program For AZD1656
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) ("Conduit Pharmaceuticals" or "Conduit"), a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, today